United States · FDA National Drug Code directory

Lamotrigine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 0115-9939_813e9f35-df9e-428a-9f4f-1a312c86f937
Product NDC: 0115-9939
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: LAMOTRIGINE
Labeler: Amneal Pharmaceuticals of New York LLC
Marketing category: ANDA
Marketing start / end (source format): 20181227
Source listing expiry: 20261231

Source-listed ingredients

LAMOTRIGINE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (0115-9939-01) · 0115-9939-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →